AI assistant
BIO-TECHNE Corp — Director's Dealing 2020
Aug 11, 2020
30718_dirs_2020-08-11_1f05577d-6f71-4686-b135-440b6267c696.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-08-09
Reporting Person: Hippel James (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-09 | Common Stock | M | 4438 | — | Acquired | 11321 | Direct |
| 2020-08-09 | Common Stock | F | 2184 | $265.76 | Disposed | 9137 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-09 | Restricted Stock Units | $ | M | 4438 | Disposed | Common Stock (4438) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (15909) | 15909 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (30400) | 30400 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (40533) | 40533 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (24460) | 24460 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (32613) | 32613 | Direct |
| Restricted Stock Units | $ | Common Stock (3383) | 3383 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (18066) | 18066 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (24089) | 24089 | Direct |
| Restricted Stock Units | $ | Common Stock (3938) | 3938 | Direct | |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (19936) | 19936 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (26581) | 26581 | Direct |
| Restricted Stock Units | $ | Common Stock (3219) | 3219 | Direct | |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (14360) | 14360 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (19147) | 19147 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325.0) | 8325.0 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F2: Fully exercisable.
F3: Options to purchase 10,134 shares vest on 8/18/2017 and options to purchase 10,133 shares vest on each of 8/18/2018, 8/18/2019 and 8/18/2020.
F4: On 8/9/2020, the Board of Directors certified vesting of 4,438 performance RSUs.
F5: Options to purchase 8,153 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and options to purchase 8,154 shares vest on 8/9/2021.
F6: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022.
F8: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
F10: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11: Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.
F12: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F13: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.